María de Fátima Higuera de la Tijera

6PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Gene and molecular therapyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2021
The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease.

Fátima Higuera-de-la-Tijera, Alfredo Servín-Caamaño, Daniel Reyes-Herrera

|Feb 11, 2021
Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience.

José Luis Pérez Hernández, Mª de Fátima Higuera de la Tijera, César Alejandro Arce Salinas

|Feb 10, 2021
Auditory and visual P300 event-related potentials to detect minimal hepatic encephalopathy.

Ángel Daniel Santana-Vargas, Fátima Higuera-De la Tijera, José Luis Pérez-Hernández

|Dec 03, 2020
Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience.

José Luis Pérez Hernández, Rodolfo Lehmann Mendoza, Javier Luna Martínez

|Jun 30, 2020
Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis.

Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera

|Aug 07, 2018
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.

Fátima Higuera-de-la-Tijera, Alfredo I Servín-Caamaño, Francisco Salas-Gordillo

Pageof 1